awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q51492680-DEEDC28D-B3AB-4B85-894B-3BACBBAA3DA4
Q51492680-DEEDC28D-B3AB-4B85-894B-3BACBBAA3DA4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51492680-DEEDC28D-B3AB-4B85-894B-3BACBBAA3DA4
A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.
P2860
Q51492680-DEEDC28D-B3AB-4B85-894B-3BACBBAA3DA4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51492680-DEEDC28D-B3AB-4B85-894B-3BACBBAA3DA4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f6971db114c886a3af8aef07fd8055c1010a765e
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.